Unity Biotechnology, Inc. Asset Impairment Charges
Unity Biotechnology, Inc. reported Asset Impairment Charges of $0 for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-04-22.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AssetImpairmentCharges · last filed 2025-04-22
- Unity Biotechnology, Inc. asset impairment charges for the quarter ending 2025-03-31 was $0.00.
- Unity Biotechnology, Inc. asset impairment charges for the quarter ending 2024-03-31 was $0.00.
- Unity Biotechnology, Inc. asset impairment charges for the quarter ending 2023-12-31 was $0.00.
- Unity Biotechnology, Inc. asset impairment charges for the quarter ending 2023-09-30 was $5.60M.
| Period end | Asset Impairment Charges 3 month | Asset Impairment Charges 6 month | Asset Impairment Charges 9 month | Asset Impairment Charges 12 month |
|---|---|---|---|---|
| 2025-03-31 | $0.00 10-Q · filed 2025-04-22 | |||
| 2024-12-31 | $2.70M 10-Q · filed 2025-04-22 | |||
| 2024-03-31 | $0.00 10-Q · filed 2025-04-22 | $0.00 derived: sum of 2 quarters · filed 2025-04-22 | $5.60M derived: sum of 3 quarters · filed 2025-04-22 | |
| 2023-12-31 | $0.00 derived: 10-Q 12 month − 10-Q 9 month · filed 2025-04-22 | $5.60M derived: sum of 2 quarters · filed 2025-04-22 | $5.60M 10-Q · filed 2025-04-22 | |
| 2023-09-30 | $5.60M 10-Q · filed 2023-11-13 | $5.60M 10-Q · filed 2023-11-13 |